Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Emergent Health Corp (EMGE)

Emergent Health Corp (EMGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade EMGE with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0012 +75.00%
on 04/09/24
0.0030 -30.00%
on 04/17/24
+0.0001 (+5.00%)
since 03/26/24
3-Month
0.0007 +200.00%
on 01/29/24
0.0041 -48.78%
on 03/14/24
+0.0014 (+200.00%)
since 01/26/24
52-Week
0.0005 +320.00%
on 11/29/23
0.0058 -63.79%
on 05/05/23
-0.0009 (-30.00%)
since 04/26/23

Most Recent Stories

More News
Regenerative Health Space Curator Announces Date for Acquisition Closing

This company develops and sells products for %RegenerativeWellBeing and through a planned acquisition, will have access to state-of-the art technology, and improve on cost of goods.

EMGE : 0.0021 (+5.00%)
Emergent's Pending Acquisition "Evolutionary Biologics" Engages "Aesthetics By Design" to Market, Sell and Distribute Regenerative Medicine Products Produced by Evolutionary Biologics with the Initial Focus Being Exo Elixir(TM)

HAUPPAUGE, NY / ACCESSWIRE / July 26, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces its pending Acquisition Evolutionary Biologics, Inc., (Evolutionary Biologics), a market leading...

EMGE : 0.0021 (+5.00%)
Emergent Closing in on Acquisition of Regen Biowellness Regens Bankruptcy Motion to Dismiss Approved Former L'Oréal President Jim Morrison Set to Join Emergents Board of Directors

HAUPPAUGE, NY / ACCESSWIRE / July 21, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces it is closing in on the acquisition of Regen Biowellness, Inc. ("Regen"), a distributor of various...

EMGE : 0.0021 (+5.00%)
Emergent Executes Letter of Intent To Acquire Evolutionary Biologics; Former L'Oréal President Jim Morrison To Become Full Time CEO of Emergent

HAUPPAUGE, NY / ACCESSWIRE / July 19, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Evolutionary Biologics, Inc., (website: Evolutionary...

EMGE : 0.0021 (+5.00%)
Emergent and Proposed Acquisition Partner Regen Biowellness to Re-Launch FDA Registered Patented Immune Booster ImmunaZin(TM) To Significantly Increase Revenues

HAUPPAUGE, NY / ACCESSWIRE / July 12, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces that upon its anticipated acquisition of Regen Biowellness ("Regen") this month, it intends to...

EMGE : 0.0021 (+5.00%)
Nutralife Biosciences Executes a Joint Venture Agreement With Emergent Health Corporation for the Co-Production, Co-Marketing, and Distribution of Emergent’s Line of Regenerative, and Other Health-Related Nutraceutical, Skincare and Pet Pro

COCONUT CREEK, FL, July 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – NutraLife Biosciences Inc. (OTC: NLBS), a manufacturer and distributor of private...

NLBS : 0.0001 (-66.67%)
EMGE : 0.0021 (+5.00%)
Emergent Executes Joint Venture Agreement with Nutralife Biosciences and Provides PharmaZu Corporate Update

HAUPPAUGE, NY / ACCESSWIRE / July 8, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces it has executed a joint venture agreement with Nutralife Biosciences, Inc. ("Nutralife") (OTC "NLBS")...

EMGE : 0.0021 (+5.00%)
Emergent executes Letter of Intent with Regen Biowellness, Inc.; Former L'Oréal President Jim Morrison to join Emergents Management Team

HAUPPAUGE, NY / ACCESSWIRE / July 6, 2022 / Emergent Health Corp. ("Emergent") (OTC PINK:EMGE) announces it has executed a Letter of Intent to acquire Regen Biowellness, Inc., f/k/a Availa Bio, Inc. ("Regen"),...

EMGE : 0.0021 (+5.00%)
Emergent Health Executes Binding Letter of Intent to Acquire Fusion Specialty Pharmacy

HAUPPAUGE, NY / ACCESSWIRE / June 29, 2022 / Emergent Health Corp., (OTC PINK:EMGE) executes Binding Letter of Intent to acquire Fusion Specialty Pharmacy subject to financing and execution of certain...

EMGE : 0.0021 (+5.00%)
Emergent Health Subsidiary PharmaZu Executes Agreement with DynaCord to Develop Various Injectable and Topical Biologic Exosomes for the Treatment of Arthritis, Joint Care, Wound Care, and Inflammation for Pets

KING OF PRUSSIA, PA / ACCESSWIRE / March 2, 2022 / Emergent Health Corp., (OTC PINK:EMGE) announces subsidiary PharmaZu executes an Agreement with DynaCord, LLC. of Baton Rouge, LA for the co-development...

EMGE : 0.0021 (+5.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.0021
2nd Resistance Point 0.0021
1st Resistance Point 0.0021
Last Price 0.0021
1st Support Level 0.0021
2nd Support Level 0.0021
3rd Support Level 0.0021

See More

52-Week High 0.0058
Fibonacci 61.8% 0.0038
Fibonacci 50% 0.0032
Fibonacci 38.2% 0.0025
Last Price 0.0021
52-Week Low 0.0005

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar